Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/11/2003CN1423658A Modulation of human sodium channels in dorsal root ganglia
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423565A 精子因子oscillogenin Sperm factor oscillogenin
06/11/2003CN1423520A Compositions and methods for modulation of plant cell division
06/11/2003CN1422954A Human interferon alpha 2a gene cDNA code modification recombination sequence
06/11/2003CN1422953A Gene sequence of Japanese shistosome China mainland strain gynecophoric canal protein
06/11/2003CN1422870A Fusional protein with intensified activity of internal red-blood-cell formation element
06/11/2003CN1422867A Method for extracting and separating haematoglobin from animal blood
06/11/2003CN1422866A Effective renaturation liquid of human interferon inclusion body comprising D-sorbiol and renaturation method
06/11/2003CN1422865A Effective renaturation liquid of recombinant human interon inclusion body and renaturation method
06/11/2003CN1422864A Zinc finger protein and its antibody preparation and use
06/11/2003CN1422863A Recombinant chimeric peptide antigen detecting HCMV antibody and production method thereof
06/11/2003CN1422665A Method for producing marker vaccinum of resisting mammal virus
06/11/2003CN1422610A Peparation of human recombined blood-vessel generation element and skin whitening product
06/10/2003US6576820 Rice cell transformed with a gene encoding the protein; useful as an ingredient in food and for preventing and treating arteriosclerosis and coronary heart diseases; lowers serum cholesterol
06/10/2003US6576815 Promoter sequence expressed in anthers and pollens
06/10/2003US6576814 Decreasing the expression of a nucleotide sequence; corn
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576757 Polynucleotides encoding flavivirus and alphavirus multivalent antigenic polypeptides
06/10/2003US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer
06/10/2003US6576755 Beta-defensins
06/10/2003US6576754 Genetically engineered nucleic acids; proteins, fusion proteins and active fragments stimulate leukocyte response
06/10/2003US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
06/10/2003US6576750 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs
06/10/2003US6576745 Human cystatin F antibodies
06/10/2003US6576744 Cytokine receptor zalpha11
06/10/2003US6576743 Of given amino acid sequence; useful for promoting wound healing and stimulating platelet proliferation; can use in treating autoimmune diseases and cancer
06/10/2003US6576742 DNA sequence encoding a human imidazoline receptor and method for cloning the same
06/10/2003US6576741 Of given amino acid sequence; can use in determining the presence of virulent bacteria in a sample and for vaccine compositions
06/10/2003US6576676 Means for the modulation of processes mediated by retinold receptors and compounds useful therefor
06/10/2003US6576658 Compositions and uses of dictyostatin compounds
06/10/2003US6576610 Includes substructure with thrombogenic potential operably linked to selective recognition domain; interacts with function forming context expressed by cells or tissues
06/10/2003US6576609 Methods and compositions for generating angiostatin
06/10/2003US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell
06/10/2003US6576607 Methods using CNS neurite outgrowth modulators
06/10/2003US6576475 Assay system and novel labelled compounds for use therewith
06/10/2003US6576469 Inducible methods for repressing gene function
06/10/2003US6576468 Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells
06/10/2003US6576467 Methods for producing recombined antibodies
06/10/2003US6576456 Chimeric adenovirus fiber protein
06/10/2003US6576455 Structure-based designed herbicide resistant products
06/10/2003US6576453 Thermostable DNA ligase mutants
06/10/2003US6576445 Chemokine α-4
06/10/2003US6576444 IRAK3 polynucleotides
06/10/2003US6576443 Adjustment of gene expression
06/10/2003US6576442 rdgB proteins and related products and methods
06/10/2003US6576441 Isolated nucleic acid comprising a polynucleotide of given sequence; collapses growth cones of dorsal root ganglion cells and inhibits neurite outgrowth; can use in central nervous system neuron regeneration
06/10/2003US6576440 Treating a wound with an invasion inducing agent such as peptides containing PHSRN sequence
06/10/2003US6576437 Stimulus-inducible protein kinase complex and methods of use therefor
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576432 That bind integrin; can use in controlling cell adhesion
06/10/2003US6576427 Human cartilage glycoprotein
06/10/2003US6576418 Method for determining the nucleotide sequence of the gene for the α5(IV) chain of human type IV collagen
06/10/2003US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus
06/10/2003US6576243 Polynucleotide vaccine formula against porcine reproductive and respiratory pathologies
06/10/2003US6576240 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
06/10/2003US6576238 Isolated protein selected from protein having specified amino acid sequence, or protein comprising homologue of flea protein comprising portion of specified amino acid sequence, which elicits antibody response against flea protein
06/10/2003US6576237 Vertebrate tissue pattern-inducing proteins, and uses related thereto
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003US6576232 Composition comprising mutant human interleukin 13 molecule comprising polypeptide having specified amino acid sequence
06/10/2003US6575751 Interactive dental restorative network
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/10/2003CA2143416C Inhibitor of collagen-stimulated platelet aggregation
06/10/2003CA2121121C Preparation of recombinant borrelia proteins
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/10/2003CA2065553C Stabilized factor viii preparations
06/10/2003CA2065323C Isolation and purification of lung surfactant protein
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003046578A2 Method for the assessment and prognosis of sarcoidosis
06/05/2003WO2003046575A1 Biopolymer marker indicative of normal human
06/05/2003WO2003046574A2 Complement c3 precursor biopolymer markers indicative of insulin resistance
06/05/2003WO2003046572A2 Biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046571A2 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046570A2 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046569A1 Fibronectin precursor biopolymer marker predictive of alzheimers disease
06/05/2003WO2003046567A2 Protein biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046566A2 Pedf biopolymer markers predictive of alzheimers disease
06/05/2003WO2003046560A2 Self-assembly molecules
06/05/2003WO2003046555A1 Determining antibody specificity
06/05/2003WO2003046552A2 Screening method for compounds that modulate neuronal activity
06/05/2003WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
06/05/2003WO2003046212A2 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003046196A1 Secreted proteins
06/05/2003WO2003046190A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
06/05/2003WO2003046187A1 Method for producing a recombinant polypeptide
06/05/2003WO2003046183A2 Streptococcus suis avirulent vaccine and uses in antibiotic design
06/05/2003WO2003046182A1 Human glioma antigen originating in testis
06/05/2003WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells
06/05/2003WO2003046180A2 Human cdnas and proteins and uses thereof
06/05/2003WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof
06/05/2003WO2003046176A2 Protein-protein interactions in human immunodeficiency virus
06/05/2003WO2003046172A2 Alzheimer’s disease model
06/05/2003WO2003046162A2 Process for the production of polypeptides in mammalian cell cultures
06/05/2003WO2003046160A2 Methods of increasing protein expression levels
06/05/2003WO2003046158A1 A method for preparing the recombinant human glucagon like peptide-1 (7-37)
06/05/2003WO2003046152A2 Molecules for disease detection and treatment
06/05/2003WO2003046151A2 Nucleic acid-associated proteins
06/05/2003WO2003046150A2 Glycoprotein remodeling using endoglycanases
1 ... 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 ... 2916